Mutations of TP53, the gene encoding the tumor suppressor p53, are the most common genetic alteration in HNSCC and recent studies suggest mutation rates of up to 85% in HPV-negative disease [41]. Here, TP53 is linked to head and neck squamous cell carcinoma.